DESyne X2 Post Market Follow-up Study
NCT04375085
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
49
Enrollment
INDUSTRY
Sponsor class
Stopped
Enrollment was delayed and could not be completed as planned
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Percutaneous Coronary Intervention
Sponsor
Elixir Medical Corporation